BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $296M | −2.4% | 8.0% | 6.1% |
| Stock-based compensation (TTM) | $296M |
|---|---|
| YoY | −2.4% |
| 5-year CAGR | 8.0% |
| 10-year CAGR | 6.1% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $291M | −0.1% |
| 2024 | $291M | +10.2% |
| 2023 | $264M | +4.0% |
| 2022 | $254M | +6.5% |
| 2021 | $239M | +20.3% |
| 2020 | $198M | +8.8% |
| 2019 | $182M | +15.7% |
| 2018 | $158M | +23.0% |
| 2017 | $128M | −17.3% |
| 2016 | $155M | −4.1% |
| 2015 | $161M | +3.9% |
| 2014 | $155M | +13.9% |
| 2013 | $136M | +15.0% |
| 2012 | $119M | +4.9% |
| 2011 | $113M | −32.7% |
| 2010 | $168M | +4.3% |
| 2009 | $161M | +10.1% |
| 2008 | $146M | +18.7% |
| 2007 | $123M | — |